ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 16 (4) 1261 -1272     DOI: 10.1677/ERC-08-0289
Copyright © 2009 by the Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ERC-08-0289v1
16/4/1261    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Ameur, N.
Right arrow Articles by Bidart, J.-M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ameur, N.
Right arrow Articles by Bidart, J.-M.

Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways

Nabahet Ameur1, Ludovic Lacroix1,2, Sophie Roucan3, Véronique Roux3, Sophie Broutin2, Monique Talbot1, Corinne Dupuy1, Bernard Caillou2, Martin Schlumberger4 and Jean-Michel Bidart1,2

1 CNRS FRE 2939
2 Translational Research Laboratory
3 , Functional Genomic Unit
4 Department of Nuclear Medicine and Endocrine Oncology, Institut de Cancérologie Gustave-Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France

(Correspondence should be addressed to J-M Bidart at Institut de Cancérologie Gustave-Roussy; Email: bidart{at}igr.fr)

RET oncogene mutations are found in familial medullary thyroid carcinomas (MTC) and in one-third of sporadic cases. Oncogenic mechanisms involved in non-RET mutated sporadic MTC remain unclear. To study alterations associated with the development of both inherited and sporadic MTC, pangenomic DNA microarrays were used to analyze the transcriptome of 13 MTCs (four familial and nine sporadic). By using an ANOVA test, a list of 173 gene sequences with at least a twofold change expression was obtained. A subset of differentially expressed genes was controlled by real-time quantitative PCR and immunohistochemistry on a larger collection of MTCs. The expression pattern of those genes allowed us to distinguish two groups of sporadic tumors. The first group displays an expression profile similar to that expressed by inherited RET634 tumors. The second presents an expression profile close to that displayed by inherited RET918 tumors and includes tumors from patients with distant metastases. It is characterized by the overexpression of genes involved in proliferation and invasion (PTN, ESM1, and CEACAM6) or matrix remodeling (COL1A1, COL1A2, and FAP). Interestingly, RET918 tumors showed overexpression of the PTN gene, encoding pleiotrophin, a protein associated with metastasis. Using a MTC cell line, silencing of RET induced the inhibition of PTN gene expression. Overall, our results suggest that familial MTC and sporadic MTC could activate similar oncogenic pathways.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Society for Endocrinology.